MTHFD2 contributes to tumorigenesis and immune evasion in a variety of cancers, and induces immune escape through upregulation of PD-L1 in pancreatic and bladder cancers (Li et al. 2023; Shang et al. 2021). This evidence concerns the gene MTHFD2 and urinary bladder carcinoma.